MIR6069

Across TCGA pan-cancer cohorts, MIR6069 RNA is linked to patient survival in 12 of 34 cancer types, making it the most broadly survival-associated MIR6069 data layer.

The strongest signal is observed in testicular germ cell tumors (TGCT), where higher MIR6069 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated MIR6069 expression acts as an unfavorable survival marker, although some lineages such as LAML and ESCA show a favorable association.

TGCT, KICH, and LUAD are the cancer types where MIR6069 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
TGCT	DFS	Tertile	II,III,IV	0.363	0.954	<.001	102	view →
KICH	OS	Quartile	III,IV	0.159	0.831	<.001	51	view →
LUAD	DFS	Median	IV	0.509	0.812	.020	24	view →
KIRC	OS	Quartile	All	0.745	0.819	.012	15	view →
SKCM	DFS	Tertile	All	0.125	0.265	.004	12	view →
BRCA	DFS	Tertile	All	0.868	0.912	.028	10	view →
LAML	DFS	Quartile	All	0.754	0.479	.031	10	view →
READ	DFS	Tertile	II,III,IV	0.473	0.705	.018	9	view →
ESCA	DFS	Median	All	0.912	0.549	.029	6	view →
SARC	OS	Tertile	All	0.948	0.805	.039	6	view →
THYM	OS	Tertile	II,III,IV	0.778	0.982	.036	3	view →
DLBC	DFS	Quartile	All	1.000	0.438	.048	1	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 12 lineages.

MIR6069–TGCT (DFS)

Open the TGCT breakdown →